Microbiome pipeline constitutes 130+ key companies continuously working towards

developing 200+ Microbiome treatment therapies, analyzes DelveInsight

Microbiome is the collection of all microbes, such as bacteria, fungi, viruses, and their genes, that naturally live on our bodies and inside us. Although microbes are so small that they require a microscope to see them, they contribute in big ways to human health and wellness. They protect us against pathogens, help our immune system develop, and enable us to digest food to produce energy.

DelveInsight, “Microbiome Competitive landscape, 2022,” report provides

comprehensive insights about 130+ companies and Microbiome drugs in Microbiome

inhibitors Competitive landscape. It covers the therapeutics assessment by product type,

stage, route of administration, and molecule type. It further highlights the inactive pipeline

products in this space.

To know more about the Microbiome Competitive landscape report, click here:

Microbiome Competitive landscape

Key Takeaways from the Microbiome Competitive landscape report:

 

Leading Microbiome Companies working in the market are Evelo Biosciences, Vedanta Biosciences, MatriSys Biosystem, 4D Pharma, AOBiome, Caelus Health, DA Volterra, Debiopharm, Enterome Bioscience, Rebiotix, Finch Therapeutics Group, Igen Biotech Group, ImmuneBiotech, Precigen Inc, Immuron, Kaleido Biosciences, YSOPIA Bioscience, MaaT Pharma, Microbiome Therapeutics, MyBiotics, Naked Biome, Nubiyota, OxThera, Pylum Biosciences, Ritter Pharmaceuticals, Seres Therapeutics, Symberix and Others.

 

Key Microbiome therapies in various stages of development include RBX 2660, DAV 132, B244, EDP1815, Blautix, MRx518, MSB- 01, VE-202, ABI M201, AZT-04, MaaT 033, MSB 3163 and Others.

 

In May 2022, Gnubiotics Sciences SA, announced a strategic partnership agreement with ADM,a global leader in human and animal nutrition.The strategic partnership is centered on the commercialization of innovative microbiome solutions for companion animal health and wellbeing.

DelveInsight’s Microbiome Report covers around 200+ products under different phases of clinical development like

 

Assessment by Microbiome Product TypeAssessment by Stage and Product Type of MicrobiomeAssessment by Route of AdministrationAssessment by Stage and Route of Administration of MicrobiomeAssessment by Microbiome Molecule TypeAssessment by Stage and Molecule Type of Microbiome

Emerging Microbiome Drugs Under Different Phases of Clinical Development Include:

Some of the Microbiome therapies are B244, VE202 and Many Others.

 

Further Microbiome product details are provided in the report. Download the

Microbiome Pipeline report to learn more about the emerging Microbiome therapies

at: Microbiome Therapeutics

 

Key companies in the  Microbiome Therapeutics Market:

Some of the  Microbiome Companies working in the market are  Evelo Biosciences, Vedanta Biosciences, MatriSys Biosystem, 4D Pharma, AOBiome, Caelus Health, DA Volterra, Debiopharm, Enterome Bioscience, Rebiotix, Finch Therapeutics Group, Igen Biotech Group, ImmuneBiotech, Precigen Inc, Immuron, Kaleido Biosciences, YSOPIA Bioscience, MaaT Pharma, Microbiome Therapeutics, MyBiotics, Naked Biome, Nubiyota, OxThera, Pylum Biosciences, Ritter Pharmaceuticals, Seres Therapeutics, Symberix and Others.

 

 

Request for Sample PDF Report to know in detail about the recent developments  and

advancements in Microbiome clinical trials– Phases of Microbiome Drugs in pipeline

 

Table of Content (TOC)

Microbiome Pipeline Report IntroductionMicrobiome Pipeline Report Executive SummaryMicrobiome Pipeline: Overview Analytical Perspective In-depth Commercial AssessmentMicrobiome Clinical Trial TherapeuticsMicrobiome Pipeline: Late Stage Products (Pre-registration)Microbiome Pipeline: Late Stage Products (Phase III)Microbiome Pipeline: Mid Stage Products (Phase II)Microbiome Pipeline: Early Stage Products (Phase I)Microbiome Pipeline Therapeutic Assessment Inactive Products in the Microbiome Pipeline Company-University Collaborations (Licensing/Partnering) Analysis Key Microbiome Companies Key Products in the Microbiome Pipeline Unmet NeedsMicrobiome Market Drivers and Barriers Future Perspectives and Conclusion Analyst Views Appendix

Download Sample PDF Report to know more about @ Microbiome drugs and medication

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused

exclusively on life sciences. It supports pharma companies by providing comprehensive end-

to-end solutions to improve their performance.